Chemours CC Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Chemours in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The official record: Chemours’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Chemours's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Chemours's cash & equivalents?
- Chemours (CC) reported cash & equivalents of $563M in Q1 2026.
- How has Chemours's cash & equivalents changed year-over-year?
- Chemours's cash & equivalents increased by 21.3% year-over-year, from $464M to $563M.
- What is the long-term trend for Chemours's cash & equivalents?
- Over 5 years (2020 to 2025), Chemours's cash & equivalents has grown at a -9.5% compound annual growth rate (CAGR), from $1.11B to $670M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.